Teva Pharmaceutical Industries Limited Stock Forecast
Evaluation of Teva Pharmaceutical Industries Limited stock downgraded after the last trading session.
(Updated on Mar 28, 2024)
The Teva Pharmaceutical Industries Limited stock price fell by -2.22% on the last day (Thursday, 28th Mar 2024) from $14.43 to $14.11. During the last trading day the stock fluctuated 3.15% from a day low at $13.97 to a day high of $14.41. The price has risen in 7 of the last 10 days and is up by 4.52% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 million shares and in total, 10 million shares were bought and sold for approximately $144.58 million.
The stock lies in the middle of a strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 30.43% during the next 3 months and, with a 90% probability hold a price between $17.87 and $18.89 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
TEVA Signals & Forecast
The Teva Pharmaceutical Industries Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $13.98 and $13.36. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, March 27, 2024, and so far it has fallen -2.22%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Teva Pharmaceutical Industries Limited stock
On the downside, the stock finds support just below today's level from accumulated volume at $12.10 and $11.73. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Teva Pharmaceutical Industries Limited finds support just below today's level at $12.10. If this is broken, then the next support from accumulated volume will be at $11.73 and $11.49.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.440 (3.15%) between high and low. For the last week, the stock has had daily average volatility of 2.23%.
Our recommended stop-loss: $13.46 (-4.62%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 1 day ago.)
Trading Expectations (TEVA) For The Upcoming Trading Day Of Monday 1st
For the upcoming trading day on Monday, 1st we expect Teva Pharmaceutical Industries Limited to open at $14.16, and during the day (based on 14 day Average True Range), to move between $13.78 and $14.44, which gives a possible trading interval of +/-$0.334 (+/-2.37%) up or down from last closing price. If Teva Pharmaceutical Industries Limited takes out the full calculated possible swing range there will be an estimated 4.73% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $14.14 (0.21%) than the support at $12.10 (14.25%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Teva Pharmaceutical Industries Limited stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Teva Pharmaceutical Industries Limited stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.
Current score: 1.510 Buy Candidate Downgraded
Predicted Opening Price for Teva Pharmaceutical Industries Limited of Monday, April 1, 2024
Fair opening price April 1, 2024 | Current price |
---|---|
$14.16 ( 0.378%) | $14.11 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for TEVA
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 14.60 | 3.50 % | |
R2 | 14.44 | 2.31 % | ||
R1 | 14.33 | 1.57 % | ||
Current price: | 14.11 | |||
Support | S1 | 14.00 | -0.81 % | |
S2 | 13.89 | -1.55 % | ||
S3 | 13.72 | -2.74 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 0 | . | |
R2 | 14.43 | 2.27 % | ||
R1 | 14.14 | 0.213 % | ||
Current price | 14.11 | |||
Support | S1 | 12.10 | -14.25% | |
S2 | 11.73 | -16.87% | ||
S3 | 11.49 | -18.57% |
TEVA Dividend Payout History
# | Ex-Date | Pay Date | Amount | Yield | |
---|---|---|---|---|---|
1 | Nov 02, 2017 | Nov 27, 2017 | Dec 12, 2017 | $0.0850 | 0.515% |
2 | Aug 07, 2017 | Aug 25, 2017 | Sep 14, 2017 | $0.0850 | 0.463% |
3 | May 11, 2017 | Jun 01, 2017 | Jun 22, 2017 | $0.340 | 1.05% |
4 | Feb 13, 2017 | Feb 28, 2017 | Mar 20, 2017 | $0.340 | 1.01% |
5 | Nov 15, 2016 | Dec 01, 2016 | Dec 20, 2016 | $0.340 | 0.94% |
FAQ
Click here for our free guide on how to buy Teva Pharmaceutical Industries Limited Stock.